Publicacions científiques

Pandolfo M, Reetz K, Darling A, Rodriguez de Rivera FJ, Henry PG, Joers J, Lenglet C, Adanyeguh I, Deelchand D, Mochel F, Pousset F, Pascual S, Van den Eede D, Martin-Ugarte I, Vilà-Brau A, Mantilla A, Pascual M, Martinell M, Meya U, Durr A

Any publicació:

2022

Número de revista:

Neurology® Genetics. vol. 8 n. 6

https://ng.neurology.org/content/8/6/e200034

Article

Efficacy and Safety of Masitinib in Progressive Forms of Multiple Sclerosis: A Randomized, Phase 3, Clinical Trial.

Autor/s:

Vermersch P, Brieva-Ruiz L, Fox RJ, Paul F, Ramio-Torrenta L, Schwab M, Moussy A, Mansfield C, Hermine O, Maciejowski M; AB07002 Study Group.

Any publicació:

2022

Número de revista:

Neurology Neuroimmunology & Neuroinflammation vol. 9 n. 3

https://nn.neurology.org/content/9/3/e1148

Article de revisió

Efficacy and safety of mirabegron for treatment of neurogenic detrusor overactivity in adults with spinal cord injury or multiple sclerosis: a systematic review.

Autor/s:

Akkoc Y.

Review

Any publicació:

2022

Número de revista:

Spinal Cord vol. 60 n. 10

https://www.nature.com/articles/s41393-022-00853-3

Article

Efficacy and safety of onabotulinumtoxinA with standardized physiotherapy for the treatment of pediatric lower limb spasticity: A randomized, placebo-controlled, phase III clinical trial.

Autor/s:

Dimitrova R, Kim H, Meilahn J, Chambers HG, Racette BA, Bonikowski M, Park ES, McCusker E, Liu C, Brin MF.

Any publicació:

2022

Número de revista:

NeuroRehabilitation vol. 50 n. 1

https://content.iospress.com/articles/neurorehabilitation/nre210070

Article de revisió

Efficacy and safety of pharmacological, physical, and psychological interventions for the management of chronic pain in children: a WHO systematic review and meta-analysis.

Autor/s:

Fisher E, Villanueva G, Henschke N, Nevitt SJ, Zempsky W, Probyn K, Buckley B, Cooper TE, Sethna N, Eccleston C.

Systematic Review and Meta-Analysis

Any publicació:

2022

Número de revista:

Pain vol. 163 n. 1

https://journals.lww.com/pain/Fulltext/2022/01000/Efficacy_and_safety_of_pharmac…

Una iniciativa de:

Cercador

Effects of Vitamin D and Body Mass Index on Disease Risk and Relapse Hazard in Multiple Sclerosis: A Mendelian Randomization Study.

Effects of whole-body vibration on neuropathic pain and the relationship between pain and spasticity in persons with spinal cord injury.

Effects of Wii Fit Rehabilitation on Lower Extremity Functional Status in Adults With Severe Burns: A Randomized Controlled Trial.

Efficacy and safety of amantadine as a treatment for apathy after brain injury: Two single-case experimental design studies.

Efficacy and safety of different drug treatments in patients with spinal-cord injury-related neuropathic pain: a network meta-analysis.

Efficacy and Safety of Leriglitazone in Patients With Friedreich Ataxia: A Phase 2 Double-Blind, Randomized Controlled Trial (FRAMES)

Efficacy and Safety of Masitinib in Progressive Forms of Multiple Sclerosis: A Randomized, Phase 3, Clinical Trial.

Efficacy and safety of mirabegron for treatment of neurogenic detrusor overactivity in adults with spinal cord injury or multiple sclerosis: a systematic review.

Efficacy and safety of onabotulinumtoxinA with standardized physiotherapy for the treatment of pediatric lower limb spasticity: A randomized, placebo-controlled, phase III clinical trial.

Efficacy and safety of pharmacological, physical, and psychological interventions for the management of chronic pain in children: a WHO systematic review and meta-analysis.

Trobes a faltar informació? Fes-nos arribar els teus suggeriments!